Alpha methyldopa-chlorpromazine interaction in schizophrenic patients
Chouinard, G.; Pinard, G.; Prenoveau, Y.; Tetreault, L.
Current Therapeutic Research 15(2): 60-72
1973
ISSN/ISBN: 0011-393X PMID: 4632508 Document Number: 69001
Document emailed within 1 workday
Related Documents
Rankin, G.O.; Watkins, B.E.; Sawutz, D.G. 1982: Chlorpromazine interactions with guanethidine and alpha-methyldopa: effects on arterial pressure control and heart rate in renovascular hypertensive rats Archives Internationales de Pharmacodynamie et de Therapie 260(1): 130-140Chaudhary, A.K.; Hubbard, J.W.; McKay, G.; Midha, K.K. 1988: Identification of a quaternary ammonium-linked glucuronide of chlorpromazine in the urine of a schizophrenic patient treated with chlorpromazine Drug Metabolism and Disposition: the Biological Fate of Chemicals 16(3): 506-508
Carlsson, C.; Dencker, S.J.; Grimby, G.; Häggendal, J.; Johnsson, G. 1976: Hemodynamic effects of thiothixene and chlorpromazine in schizophrenic patients at rest and during exercise International Journal of Clinical Pharmacology and Biopharmacy 13(4): 262-268
Clineschmidt, B.V.; Flataker, L.M.; Faison, E.P.; Haubrich, D.R. 1980: Alpha-methyldopa reduces locomotor activity in rats via its metabolite, alpha-methylnorepinephrine, acting on alpha 2-adrenoceptors Archives Internationales de Pharmacodynamie et de Therapie 244(2): 231-243
During, R.; Schwarzlos, G. 1985: Effect of alpha-methyldopa (Dopegyt) on blood pressure in hypertensive pregnant patients Zentralblatt für Gynakologie 107(6): 357-362
Onstad, S.; Skre, I.; Torgersen, S.; Kringlen, E. 1994: Family interaction: parental representation in schizophrenic patients Acta Psychiatrica Scandinavica. Supplementum 384: 67-70
Carpentiere, G.; Castello, F.; Marino, S. 1984: Effect of alpha-methyldopa in single and divided doses on the circadian rhythm of arterial pressure in hypertensive patients La Clinica Terapeutica 108(6): 497-502
Rice, H.E.; Smith, C.B.; Silk, K.R.; Rosen, J. 1984: Platelet alpha 2-adrenergic receptors in schizophrenic patients before and after phenothiazine treatment Psychiatry Research 12(1): 69-77
Bhattacharyya, M.; Chaudhuri, U.; Poddar, R.K. 1990: Interaction of chlorpromazine with hemoglobin Indian Journal of Biochemistry and Biophysics 27(4): 240-244
Farsang, C. 1986: Update on alpha-methyldopa Therapia Hungarica 34(3): 139-149
Taylor, P.; Gillman, P.K.; Gaind, R. 1978: Alpha-methyldopa in schizophrenia Journal of Clinical Psychiatry 39(11): 815-816
Bralet, M.C.; Yon, V.; Loas, G.; Noisette, C. 2000: Cause of mortality in schizophrenic patients: prospective study of years of a cohort of 150 chronic schizophrenic patients L'Encephale 26(6): 32-41
Kaplinsky, N.; Fraenkel, O. 1972: Hemolytic anemia due to alpha-methyldopa Harefuah 83(11): 487-488
Koller, O.; Lehoczky, D. 1976: Immune hemolysis in the course of alpha methyldopa therapy Orvosi Hetilap 117(9): 545-546
Uspenskiĭ, A.E.; Korobov, N.V. 1976: Facilitation of the effects of L-DOPA by alpha-methyldopa Biulleten' Eksperimental'noi Biologii i Meditsiny 81(3): 314-316
Uretsky, N.J. 1974: Effect of alpha-methyldopa on the metabolism of dopamine in the striatum of the rat Journal of Pharmacology and Experimental Therapeutics 189(2): 359-369
Káldor, A.; Kállay, K.; Sebestyén, K.; Alexits, K. 1972: The effect of alpha methyldopa and spironolactone on angiotensin sensitivity in man Orvosi Hetilap 113(1): 23-24
Beretta, R.; Cassi, E.; Colombo, A.; De Paoli, A.; Marciandi, C.; Renzetti, G.A. 1982: Treatment of hypertensive states with a combination of alpha-methyldopa and a diuretic La Clinica Terapeutica 103(5): 487-500
Yahr, M.D.; Duvoisin, R.C.; Mendoza, M.R.; Schear, M.J.; Barrett, R.E. 1971: Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486) Transactions of the American Neurological Association 96: 55-58
Sweet, R.D.; Lee, J.E.; McDowell, F. 1971: Alpha-methyldopa as an adjunct to levodopa treatment of Parkinson's disease Transactions of the American Neurological Association 96: 59-65